ZeroHarm Sciences
Type
startup
Founded
2020
Funding captured
$7.2m
Deals captured
1
About ZeroHarm Sciences
ZeroHarm Sciences develops and manufactures plant‑based nutraceuticals using proprietary nano‑formulation technology to improve bioavailability and controlled release of phytochemicals. The company tightly controls its value chain from medicinal‑plant sourcing through extraction and in‑house formulation R&D to GMP manufacturing. ZeroHarm works with a network of over 10,000 farmers across Northeast India and the Himalayan region, conducts extraction at the Guwahati Biotech Park, and has filed and received patents for nano‑formulations including turmeric‑based phytochemicals, iron‑folic acid combinations, carotenoid‑based eye health solutions, and synbiotic gut health compositions. Its portfolio spans 60+ SKUs across diabetes management, heart health, joint care, immunity, gut health, oncology support, women’s wellness and performance nutrition, and its products are sold via its D2C website, marketplaces (including Amazon and Flipkart) and quick‑commerce platforms; the brand reports having served over 300,000 customers.
ZeroHarm Sciences funding captured (1)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Series A | Feb 25, 2026 | $7.2m |